updated 1/23/2008 8:58:25 AM ET 2008-01-23T13:58:25

Pfizer Inc., the world's largest drug maker, said Wednesday its fourth-quarter profit fell 70 percent from a year-ago period that included the sale of the company's consumer health business, but adjusted profit topped Wall Street expectations.

For the three months ended Dec. 31, net income fell to $2.88 billion, or 42 cents per share, from $9.45 billion, or $1.32 per share, a year ago, which included divestiture gains of $1.11 per share. Excluding items, net income in the latest period totaled $3.6 billion, or 52 cents per share.

Revenue climbed 4 percent to $13.07 billion from $12.60 billion in the 2006 period, as international sales — buoyed by the weaker dollar — helped offset the loss of patent protection on blood pressure drug Norvasc and antidepressant Zoloft. Sales of blockbuster cholesterol drug Lipitor, the world's best-selling drug, rose 3 percent to $3.4 billion, as the weaker dollar helped offset slower U.S. sales.

Analysts polled by Thomson Financial, on average, forecast fourth-quarter profit of 47 cents per share on $12.19 billion in revenue.

The company raised its outlook for 2008 revenue to a range of $47 billion to $49 billion, from a range of $46.5 billion to $48.5 billion previously. It also forecast adjusted earnings per share of $2.35 to $2.45 for the year.

Wall Street has forecast fiscal 2008 revenue of $47.12 billion and earnings per share of $2.34.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com